Neuraminidase inhibitors as antivirals (Q44057778)

29 November 2017

title

Neuraminidase inhibitors as antivirals (English)

1 reference

29 November 2017

Colman PM

1

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

20 Suppl 2

1 reference

29 November 2017

page(s)

S55-8

1 reference

The inhibition of neuraminidase and antiviral action

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Influenza virus neuraminidase: structure, antibodies, and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900132-9

7 January 2021

10.1016/S0264-410X(02)00132-9

Identifiers

DOI

1 reference

29 November 2017

1 reference